21 May 2013
Keywords: roche, buy, nimblegen, 5m, swiss, drug, major
Article | 25 June 2007
Swiss drug major Roche has signed a definitive agreement to acquire 100% of NimbleGen, a privately-held, Madison, Wisconsin, USA-based company
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 June 2007
20 May 2013
© 2013 thepharmaletter.com